本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Enliven Treateutics

22.45
-0.3300-1.45%
盘后22.450.00000.00%16:10 EDT
成交量:34.35万
成交额:776.83万
市值:12.90亿
市盈率:-11.62
高:23.21
开:22.53
低:21.99
收:22.78
数据加载中...
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/04/27

SEC问询函

Form CORRESP - Correspondence
2024/04/19

SEC问询函

Form CORRESP - Correspondence
2024/04/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/11

重要事件披露

Form 8-K - Current report
2024/04/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/09

重要事件披露

Form 8-K - Current report
2024/04/04

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]